Angelo Veronese

12.2k total citations · 3 hit papers
53 papers, 8.9k citations indexed

About

Angelo Veronese is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Angelo Veronese has authored 53 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 26 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Angelo Veronese's work include MicroRNA in disease regulation (21 papers), RNA modifications and cancer (12 papers) and Epigenetics and DNA Methylation (11 papers). Angelo Veronese is often cited by papers focused on MicroRNA in disease regulation (21 papers), RNA modifications and cancer (12 papers) and Epigenetics and DNA Methylation (11 papers). Angelo Veronese collaborates with scholars based in Italy, United States and United Kingdom. Angelo Veronese's co-authors include Massimo Negrini, Manuela Ferracin, Carlo M. Croce, George A. Calin, Silvia Sabbioni, Chang‐Gong Liu, Stefano Volinia, Riccardo Spizzo, Laura Gramantieri and Patrizia Querzoli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Angelo Veronese

53 papers receiving 8.7k citations

Hit Papers

MicroRNA Gene Expression Deregulation in Human Breast Cancer 2005 2026 2012 2019 2005 2007 2008 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MicroRNA Gene Expression Deregulation in Human Breast Cancer
    2005 3.3k citations Marilena V. Iorio, Manuela Ferracin et al. Cancer Research profile →
  2. Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma
    2007 670 citations Laura Gramantieri, Manuela Ferracin et al. Cancer Research profile →
  3. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
    2008 517 citations Francesca Fornari, Laura Gramantieri et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Veronese Italy 36 7.2k 6.5k 834 517 476 53 8.9k
Rosa Visone Italy 28 8.3k 1.1× 8.0k 1.2× 665 0.8× 563 1.1× 380 0.8× 45 10.0k
Erik A. Wentzel United States 12 7.5k 1.0× 6.8k 1.0× 724 0.9× 506 1.0× 322 0.7× 13 8.7k
Kathryn A. O’Donnell United States 22 6.2k 0.9× 3.7k 0.6× 858 1.0× 481 0.9× 353 0.7× 37 7.5k
Andreas G. Bader United States 30 7.2k 1.0× 5.3k 0.8× 1.6k 1.9× 616 1.2× 474 1.0× 58 8.9k
Cristian Taccioli Italy 31 5.0k 0.7× 4.5k 0.7× 764 0.9× 521 1.0× 301 0.6× 69 6.5k
Fabio Petrocca United States 29 9.2k 1.3× 8.3k 1.3× 1.7k 2.0× 620 1.2× 334 0.7× 39 11.0k
Ramiro Garzon United States 42 10.9k 1.5× 8.9k 1.4× 1.1k 1.3× 1.0k 2.0× 543 1.1× 142 13.5k
Ondřej Slabý Czechia 47 5.7k 0.8× 5.3k 0.8× 938 1.1× 479 0.9× 424 0.9× 278 8.3k
Amelia Cimmino Italy 28 11.5k 1.6× 10.3k 1.6× 877 1.1× 1.1k 2.0× 573 1.2× 50 14.2k
Chung‐Ji Liu Taiwan 45 4.5k 0.6× 3.5k 0.5× 1.9k 2.3× 515 1.0× 290 0.6× 159 6.9k

Countries citing papers authored by Angelo Veronese

Since Specialization
Citations

This map shows the geographic impact of Angelo Veronese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Veronese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Veronese more than expected).

Fields of papers citing papers by Angelo Veronese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Veronese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Veronese. The network helps show where Angelo Veronese may publish in the future.

Co-authorship network of co-authors of Angelo Veronese

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Veronese. A scholar is included among the top collaborators of Angelo Veronese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Veronese. Angelo Veronese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grassadonia, Antonino, Vincenzo Graziano, Sara Pagotto, et al.. (2021). Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression. Cell Death Discovery. 7(1). 86–86. 5 indexed citations
2.
Pagotto, Sara, Annalisa Nicotra, Tiziana Apuzzo, et al.. (2021). A perspective analysis: microRNAs, glucose metabolism, and drug resistance in colon cancer stem cells. Cancer Gene Therapy. 29(1). 4–9. 8 indexed citations
3.
4.
Balatti, Veronica, Manuela Ferracin, Angelo Veronese, et al.. (2011). MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 6(5). 844–851. 71 indexed citations
5.
Ferracin, Manuela, Massimo Pedriali, Angelo Veronese, et al.. (2011). MicroRNA profiling for the identification of cancers with unknown primary tissue‐of‐origin. The Journal of Pathology. 225(1). 43–53. 111 indexed citations
6.
Veronese, Angelo, Laura Lupini, Jessica Consiglio, et al.. (2010). Oncogenic Role of miR-483-3p at the IGF2/483 Locus. Cancer Research. 70(8). 3140–3149. 182 indexed citations
7.
Ferracin, Manuela, Angelo Veronese, & Massimo Negrini. (2010). Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Review of Molecular Diagnostics. 10(3). 297–308. 228 indexed citations
8.
Gramantieri, Laura, Francesca Fornari, Manuela Ferracin, et al.. (2009). MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality. Clinical Cancer Research. 15(16). 5073–5081. 261 indexed citations
9.
Fornari, Francesca, Laura Gramantieri, Catia Giovannini, et al.. (2009). MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. Cancer Research. 69(14). 5761–5767. 343 indexed citations
10.
Vasilescu, Cătălin, Simona Rossi, Masayoshi Shimizu, et al.. (2009). MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis. PLoS ONE. 4(10). e7405–e7405. 301 indexed citations
11.
Volinia, Stefano, Nicoletta Mascellani, Jlenia Marchesini, et al.. (2008). Genome Wide Identification of Recessive Cancer Genes by Combinatorial Mutation Analysis. PLoS ONE. 3(10). e3380–e3380. 12 indexed citations
12.
Gramantieri, Laura, Manuela Ferracin, Francesca Fornari, et al.. (2007). Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma. Cancer Research. 67(13). 6092–6099. 670 indexed citations breakdown →
13.
Sabbioni, Silvia, Elisa Callegari, Riccardo Spizzo, et al.. (2007). Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag. Cancer Gene Therapy. 14(3). 297–305. 2 indexed citations
14.
Lanza, Giovanni, Manuela Ferracin, Roberta Gafà, et al.. (2007). mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Molecular Cancer. 6(1). 54–54. 232 indexed citations
15.
Iorio, Marilena V., Manuela Ferracin, Chang‐Gong Liu, et al.. (2005). MicroRNA Gene Expression Deregulation in Human Breast Cancer. Cancer Research. 65(16). 7065–7070. 3320 indexed citations breakdown →
16.
Miotto, Elena, Silvia Sabbioni, Angelo Veronese, et al.. (2004). Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer. Cancer Research. 64(22). 8156–8159. 81 indexed citations
17.
Cuneo, Antonio, Gian Matteo Rigolin, Renato Bigoni, et al.. (2003). Chronic lymphocytic leukemia with 6q− shows distinct hematological features and intermediate prognosis. Leukemia. 18(3). 476–483. 83 indexed citations
18.
Sabbioni, Silvia, Elena Miotto, Angelo Veronese, et al.. (2003). Multigene Methylation Analysis of Gastrointestinal Tumors. Molecular Diagnosis. 7(3). 201–207. 34 indexed citations
19.
Schwienbacher, Christine, Angelo Veronese, Laura Gramantieri, et al.. (2002). Loss of methylation at chromosome 11p15.5 is common in human adult tumors. Oncogene. 21(16). 2564–2572. 43 indexed citations
20.
Sabbioni, Silvia, Angelo Veronese, Maurizio Trubia, et al.. (1999). Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD. Cytogenetic and Genome Research. 86(3-4). 214–218. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Visone Breakdown of academic impact, for papers by Erik A. Wentzel Breakdown of academic impact, for papers by Kathryn A. O’Donnell Breakdown of academic impact, for papers by Andreas G. Bader Breakdown of academic impact, for papers by Cristian Taccioli Breakdown of academic impact, for papers by Fabio Petrocca Breakdown of academic impact, for papers by Ramiro Garzon Breakdown of academic impact, for papers by Ondřej Slabý Breakdown of academic impact, for papers by Amelia Cimmino Breakdown of academic impact, for papers by Chung‐Ji Liu
Rankless by CCL
2026